CUE PHARAM - 70% GAINS Long

Cue Biopharma, Inc.NASDAQ

Description

⋅ Mar 18, 2021 10:50 AM

- Inverse head and shoulders pattern playing out on the trendline support
- Tipranks analyst consensus $31 Target of 121% upside
- Recent insider purchases, always a good sign
- CUE-101 Phase one is looking very promising

Comments

TRADiNG_hub

⋅ Mar 18, 2021 12:46 PM

Nice Post 👏👏